"/> Novus Biologicals™ Peptide bloquant d’anticorps AT… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps ATP11B

Réf. : BL-RE-053838Réf. fabricant : 18200096 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
23200
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77190. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 19 amino acids near the amino terminus of human ATP11B.

Points forts

Source

Synthetic

(Accession #: NP_055431) The ATP11B Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-053838
Réf. fabricant18200096
Gene ID (Entrez)23200
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77190. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneATPase class VI type 11 B, ATPase IR, ATPase, class VI, type 11 B, ATPIFKIAA0956probable phospholipid-transporting ATPase IF, ATPIRMGC46576, DKFZp434J238, DKFZp434N1615, EC 3.6.3, EC 3.6.3.1
Symbole de gène(s)ATP11B
Type de produitATP11B
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne19 amino acids near the amino terminus of human ATP11B
Une question, une configuration particulière ?
Contactez-nous pour un devis.